Top 10 Developments in Lupus Nephritis

被引：5

作者：

Chen, Teresa K. ^{[1
]}

Fine, Derek M. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA

来源：

CURRENT RHEUMATOLOGY REPORTS | 2013年 / 15卷 / 09期

关键词：

Lupus nephritis; Kidney; Proliferative lupus nephritis; Membranous lupus nephritis; Renal transplantation; APOL1; Induction therapy; Maintenance therapy; Systemic lupus erythematosus; SLE; Mycophenolatemofetil; Rituximab; Treatment; Multitargeted therapy; Epidemiology; B-LYMPHOCYTE STIMULATOR; STAGE RENAL-DISEASE; MYCOPHENOLATE-MOFETIL; CONTROLLED-TRIAL; DOUBLE-BLIND; COLLAPSING GLOMERULOPATHY; MEMBRANOUS NEPHROPATHY; CLINICAL-TRIALS; ERYTHEMATOSUS; THERAPY;

D O I：

10.1007/s11926-013-0358-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Lupus nephritis affects up to 60 % of patients with systemic lupus erythematosus and is associated with worse clinical outcomes. Traditionally, it has been treated with high-dose immunosuppression consisting of cyclophosphamide and prednisone; however, recent trials have demonstrated mycophenolate mofetil as a safe and effective alternative for both induction and maintenance of disease. Other progress has been made in our understanding of the pathogenesis of lupus nephritis, outcomes in renal transplantation, and associations with genetic risk factors. This review highlights key developments in our understanding of lupus nephritis over the past decade.

引用

页数：7

共 50 条

[1]

[Anonymous], 2006, ARTHRITIS RHEUM, V54, P421

[2] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis [J].

Appel, Gerald B. ;

Contreras, Gabriel ;

Dooley, Mary Anne ;

Ginzler, Ellen M. ;

Isenberg, David ;

Jayne, David ;

Li, Lei-Shi ;

Mysler, Eduardo ;

Sanchez-Guerrero, Jorge ;

Solomons, Neil ;

Wofsy, David .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05) :1103-1112

[3] Membranous lupus nephritis [J].

Austin, HA ;

Illei, GG .

LUPUS, 2005, 14 (01) :65-71

[4] THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].

AUSTIN, HA ;

KLIPPEL, JH ;

BALOW, JE ;

LERICHE, NGH ;

STEINBERG, AD ;

PLOTZ, PH ;

DECKER, JL .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619

[5] Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy [J].

Austin, Howard A., III ;

Illei, Gabor G. ;

Braun, Michelle J. ;

Balow, James E. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (04) :901-911

[6] Lupus and Pregnancy [J].

Baer, Alan N. ;

Witter, Frank R. ;

Petri, Michelle .

OBSTETRICAL & GYNECOLOGICAL SURVEY, 2011, 66 (10) :639-653

[7] Successful treatment of class V+IV lupus nephritis with multitarget therapy [J].

Bao, Hao ;

Liu, Zhi-Hong ;

Xie, Hong-Lang ;

Hu, Wei-Xin ;

Zhang, Hai-Tao ;

Li, Lei-Shi .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (10) :2001-2010

[8] Successful mycophenolate mofetil treatment of glomerular disease [J].

Briggs, WA ;

Choi, MJ ;

Scheel, PJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) :213-217

[9] The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus [J].

Cancro, Michael P. ;

D'Cruz, David P. ;

Khamashta, Munther A. .

JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) :1066-1073

[10] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis [J].

Chan, TM ;

Li, FK ;

Tang, CSO ;

Wong, RWS ;

Fang, GX ;

Ji, YL ;

Lau, CS ;

Wong, AKM ;

Tong, MKL ;

Chan, KW ;

Lai, KN .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) :1156-1162

← 1 2 3 4 5 →